causal
Complex-Systems Modeling Rescued a Failed Parkinson's Drug
For a subset of Parkinson's tied to a mutation in the GBA1 enzyme, researchers first developed a drug using simple domino-chain reasoning (A to B) which failed in clinical trials; a second group modeled the whole enzymatic process as a complex dynamical system with feedback loops across compartments, saw exactly why the original drug failed and what to do next, and that new drug is now in clinical trials expected to complete around 2026—exemplifying the complex-systems control approach.
causalpending
Speaker
Nicole RustEvidence Quote
“they modeled the whole thing as a complex dynamical system. And they could see exactly why that drug that was originally formulated wasn't working, and they could see exactly what to do next. And so, that drug is in, that new drug is now in clinical trials”
Created: 6/13/2026, 12:22:22 AM
Your notes
Loading notes...